OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive usual care and undergo evaluation by a tumor board within 14 days of baseline.
ARM II: Patients attend a palliative care visit over 60 minutes to discuss their illness, quality of life, fears and concerns and communication preferences within 7 days of baseline. Patients also undergo evaluation by a tumor board within 14 days of baseline.
After completion of study intervention, patients are followed up 7 days after the tumor board visit and 90 days after initiation of treatment.
